« Back
Home /
Voglibose

Voglibose

Manufacturer	MedChem Express
Category	Metabolism Diabetes Cholesterol & Lipid Metabolism Regulation of Appetite Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	50 mg
Item no.	HY-B0025-50mg
Targets	Glucosidase
CASRN	83480-29-9
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Voglibose is an orally active alpha-glucosidase inhibitor that prevents the development of colorectal precancerous lesions induced by obesity and diabetes. Voglibose reduces oxidative stress in an inflammatory environment and inhibits the insulin-like growth factor/insulin-like growth factor-1 receptor (IGF/IGF-1R) functional axis[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Metabolism-sugar/lipid metabolism
MolecularWeight	267.28
Clinical_Information	Launched
Manufacturers Research_Area	Metabolic Disease
Solubility	DMSO : 100 mg/mL (ultrasonic)\|H2O : 250 mg/mL (ultrasonic)
Manufacturers Target	Glucosidase
Pathway	Metabolic Enzyme/Protease
Manufacturers Product type	Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0025-50mg-safety-datasheet.pdf